TCF7L2 and type 2 diabetes mellitus: Recently, it was shown that CRISPR-mediated deletion of the region harbouring the type 2 diabetes risk SNP rs7903146 leads to a decrease in TCF7L2 mRNA levels, while targeting it with a CRISPR transcriptional activator had the opposite effect.